These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 15165903)

  • 21. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
    Noguchi K; Katayama K; Mitsuhashi J; Sugimoto Y
    Adv Drug Deliv Rev; 2009 Jan; 61(1):26-33. PubMed ID: 19111841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution.
    Takenaka K; Morgan JA; Scheffer GL; Adachi M; Stewart CF; Sun D; Leggas M; Ejendal KF; Hrycyna CA; Schuetz JD
    Cancer Res; 2007 Jul; 67(14):6965-72. PubMed ID: 17638908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology.
    Cervenak J; Andrikovics H; Ozvegy-Laczka C; Tordai A; Német K; Váradi A; Sarkadi B
    Cancer Lett; 2006 Mar; 234(1):62-72. PubMed ID: 16337740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.
    Xia CQ; Yang JJ; Gan LS
    Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):595-611. PubMed ID: 16863427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.
    Vlaming ML; Lagas JS; Schinkel AH
    Adv Drug Deliv Rev; 2009 Jan; 61(1):14-25. PubMed ID: 19118589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABCG2: structure, function and role in drug response.
    Polgar O; Robey RW; Bates SE
    Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):1-15. PubMed ID: 18370855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.
    Hegedüs C; Telbisz Á; Hegedűs T; Sarkadi B; Özvegy-Laczka C
    Adv Cancer Res; 2015; 125():97-137. PubMed ID: 25640268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.
    Ozvegy C; Litman T; Szakács G; Nagy Z; Bates S; Váradi A; Sarkadi B
    Biochem Biophys Res Commun; 2001 Jul; 285(1):111-7. PubMed ID: 11437380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
    Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
    Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemistry and pharmacology of the human multidrug resistance gene product, ABCG2.
    Zhang JT
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):531-41. PubMed ID: 17767037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.
    Haimeur A; Conseil G; Deeley RG; Cole SP
    Curr Drug Metab; 2004 Feb; 5(1):21-53. PubMed ID: 14965249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pharmacology of ABCG2 and its role in chemoresistance.
    Stacy AE; Jansson PJ; Richardson DR
    Mol Pharmacol; 2013 Nov; 84(5):655-69. PubMed ID: 24021215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.
    Ishikawa T; Nakagawa H
    J Exp Ther Oncol; 2009; 8(1):5-24. PubMed ID: 19827267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.
    Ozvegy-Laczka C; Köblös G; Sarkadi B; Váradi A
    Biochim Biophys Acta; 2005 Feb; 1668(1):53-63. PubMed ID: 15670731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABCG2: determining its relevance in clinical drug resistance.
    Robey RW; Polgar O; Deeken J; To KW; Bates SE
    Cancer Metastasis Rev; 2007 Mar; 26(1):39-57. PubMed ID: 17323127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABCG2: a perspective.
    Robey RW; To KK; Polgar O; Dohse M; Fetsch P; Dean M; Bates SE
    Adv Drug Deliv Rev; 2009 Jan; 61(1):3-13. PubMed ID: 19135109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of breast cancer resistance protein on cancer treatment outcomes.
    Ross DD; Nakanishi T
    Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels.
    Zhang W; Mojsilovic-Petrovic J; Andrade MF; Zhang H; Ball M; Stanimirovic DB
    FASEB J; 2003 Nov; 17(14):2085-7. PubMed ID: 12958161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy.
    Ishikawa T
    Adv Drug Deliv Rev; 2009 Jan; 61(1):1-2. PubMed ID: 19124052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.